BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10912629)

  • 21. Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talc.
    Shinno Y; Kage H; Chino H; Inaba A; Arakawa S; Noguchi S; Amano Y; Yamauchi Y; Tanaka G; Nagase T
    Respirology; 2018 Jan; 23(1):55-59. PubMed ID: 28980363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions.
    Hartman DL; Gaither JM; Kesler KA; Mylet DM; Brown JW; Mathur PN
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):743-7; discussion 747-8. PubMed ID: 7682268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleurodesis for malignant pleural effusions: current controversies and variations in practices.
    West SD; Davies RJ; Lee YC
    Curr Opin Pulm Med; 2004 Jul; 10(4):305-10. PubMed ID: 15220757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Talc pleurodesis and acute respiratory distress syndrome.
    Aelony Y
    Lancet; 2007 May; 369(9572):1494-1496. PubMed ID: 17482965
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
    Kolschmann S; Ballin A; Gillissen A
    Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions.
    Ong KC; Indumathi V; Raghuram J; Ong YY
    Respirology; 2000 Jun; 5(2):99-103. PubMed ID: 10894097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thoracoscopic talc poudrage in malignant pleural effusions: effective pleurodesis despite low pleural pH.
    Aelony Y; King RR; Boutin C
    Chest; 1998 Apr; 113(4):1007-12. PubMed ID: 9554639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleural effusions.
    Noppen M; Degreve J; Mignolet M; Vincken W
    Acta Clin Belg; 1997; 52(5):258-62. PubMed ID: 9489119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful management of recurrent pneumothorax in cystic fibrosis by localized apical thoracoscopic talc poudrage.
    Noppen M; Dhondt E; Mahler T; Malfroot A; Dab I; Vincken W
    Chest; 1994 Jul; 106(1):262-4. PubMed ID: 8020281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
    Zhang W; Wang GF; Zhang H; Mu XD; Jin Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):600-2. PubMed ID: 19088831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions.
    Vargas FS; Milanez JR; Filomeno LT; Fernandez A; Jatene A; Light RW
    Chest; 1994 Dec; 106(6):1771-5. PubMed ID: 7988198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic pain due to talc pleurodesis for spontaneous pneumothorax.
    Milton R; Cale AR
    Ann Thorac Surg; 2003 Nov; 76(5):1740-1. PubMed ID: 14602332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing transforming growth factor-beta2, talc and bleomycin as pleurodesing agents in sheep.
    Lee YC; Yasay JR; Johnson JE; Parker RE; Thompson PJ; Lane KB; Light RW
    Respirology; 2002 Sep; 7(3):209-16. PubMed ID: 12153686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists.
    Lee YC; Baumann MH; Maskell NA; Waterer GW; Eaton TE; Davies RJ; Heffner JE; Light RW
    Chest; 2003 Dec; 124(6):2229-38. PubMed ID: 14665505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tunneled Pleural Catheter Placement with and without Talc Poudrage for Treatment of Pleural Effusions Due to Congestive Heart Failure.
    Majid A; Kheir F; Fashjian M; Chatterji S; Fernandez-Bussy S; Ochoa S; Cheng G; Folch E
    Ann Am Thorac Soc; 2016 Feb; 13(2):212-6. PubMed ID: 26598967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinician's perspective on pneumothorax management.
    Baumann MH; Strange C
    Chest; 1997 Sep; 112(3):822-8. PubMed ID: 9315819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Talc pleurodesis for the management of malignant pleural effusions in Japan.
    Inoue T; Ishida A; Nakamura M; Nishine H; Mineshita M; Miyazawa T
    Intern Med; 2013; 52(11):1173-6. PubMed ID: 23728550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is silver nitrate an effective means of pleurodesis?
    Bucknor A; Harrison-Phipps K; Davies T; Toufektzian L
    Interact Cardiovasc Thorac Surg; 2015 Oct; 21(4):521-5. PubMed ID: 26188199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory failure following talc pleurodesis.
    Rehse DH; Aye RW; Florence MG
    Am J Surg; 1999 May; 177(5):437-40. PubMed ID: 10365887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous pneumothorax: comparison of simple drainage, talc pleurodesis, and tetracycline pleurodesis.
    Almind M; Lange P; Viskum K
    Thorax; 1989 Aug; 44(8):627-30. PubMed ID: 2799742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.